QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is a global leader in Sample to Insight solutions that enable customers to extract and analyze molecular information from biological samples containing the building blocks of life. Our Sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis, while bioinformatics support the interpretation of complex data to deliver actionable insights. Automation solutions integrate these steps into streamlined, cost-effective workflows. QIAGEN serves more than 500,000 customers worldwide in the Life Sciences and Molecular Diagnostics. As of June 30, 2025, QIAGEN employed approximately 5,700 people across more than 35 locations.Content by QIAGEN
| 2 min read
QIAGEN Digital Insights bioinformatics bring over 25 years of expertise in expert-curated content, AI-powered proprietary algorithms and user-friendly tools to simplify NGS data analysis
| 4 min read
In the quest for personalized medicine to become reality, next-generation sequencing is key
| 4 min read
Molecular screening tools and personalized healthcare: Determining success early in drug development
By facilitating personalized healthcare, molecular techniques have the potential to significantly improve patient care,
rescue effective drugs from development failure and provide cost benefits to both healthcare systems and pharma development programs.
Page 1 of 1 - 3 Total Items
